Research & Development: Page 42

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Filling Unmet Needs for Patients David Meek, Executive VP and President, Oncology, Baxalta, talks about how pharmaceutical companies can bridge the research gap in areas of high unmet need. PV: What do you think is needed to translate scientific advances into real benefits for patients? Meek: Col...

    By David Meek • Jan. 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Brain: The Decade Ahead

    The three-pound organ — made up of more than 100 billion nerves — that serves as the center of the nervous system is one of the most complex parts of the human body. Only recently have researchers and scientists begun to understand the brain and what can go wrong. This special forum kicks off a y...

    By Denise Myshko and Robin Robinson • Jan. 1, 2016
  • cancer healthcare Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Oncology

    As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Pharma Trax

    CROs’ Use of eTMF Apps Increases: Veeva Survey  Trending Now:  A majority of CROs cite speeding study start-up as top driver for eTMF technology adoption. A significant number  of contract research organizations (CROs) are increasingly using electronic trial master file (eTMF) applications, accor...

    By PharmaVoice Team • Nov. 15, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Tools of the Trade

    TGaS Insights Launches Report Service for Pharmaceutical Commercial Leaders  Trending Now:  New service provides an “outside-in" perspective on what’s happening beyond the four walls of life-sciences companies. TGaS Insights, a division of TGaS Advisors, has launched TGaS Insights Reports, a new ...

    By PharmaVoice Team • Nov. 15, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    2016 The Year Ahead

    For this special issue — the Year in Preview: 2016 — we identified 10 major trends that are expected to continue to disrupt the industry in new and different ways. There were a multitude of industry drivers from a multitude of industry sources to consider. We identified these 10 trends — that spa...

    By Taren Grom • Nov. 15, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Brain in the Decade Ahead

    In 2013, President Obama launched the Brain Research through Advancing Innovative Neurotechnologies, or BRAIN Initiative, as a large-scale effort to equip researchers with fundamental insights necessary for treating a wide variety of brain disorders such as Alzheimer’s, schizophrenia, autism, epi...

    By Taren Grom • Nov. 15, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Smart Medtech: The Smart Healthcare Environment

    Progress in technology, coupled with medical and scientific advances, is expected to significantly change the healthcare environment. Technology companies, healthcare companies, medical device companies, and others are capitalizing on emerging technologies to provide novel healthcare solutions us...

    By Denise Myshko • Nov. 15, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    New Entrants: The Healthcare Disrupters

    The traditional boundaries between industries and areas of specialization continue to blur. Some of this is being driven by the rise of the Internet of Things and the Internet of Medical Things, as dozens of companies such as Apple, DuPont, General Electric, Google, IBM, and Samsung are shaking u...

    By Denise Myshko • Nov. 15, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Crowdsourcing is a social phenomenon that is providing a platform for everything from funding small businesses to compiling data for research and development of pharmaceuticals and medical devices. Imagine the possibilities of being able to solve and predict disease challenges through the collect...

    By Taren Grom • Oct. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Pharma Trax

    Payer Pressures, Market Access Weigh Upon Life-Sciences Strategy  Trending Now: Biotech, pharma, medical device managers find payer pressures and utilization limits sway commercialization approach. Drug makers and medical device companies are finding their biggest commercial challenges coming fro...

    By PharmaVoice Team • Oct. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Tools of the Trade

    FusionOps Launches Supply Chain Analytics Trending Now:  Cloud solution provides supply chain visibility to help pharma companies drive growth and reduce cost. FusionOps has launched FusionOps Pharma, a new analytics suite designed specifically for the pharmaceutical industry. The new cloud solut...

    By PharmaVoice Team • Oct. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    R&D Moves Slowly Toward Open Source

    Open access and crowdsourcing scientific information to accelerate research and development requires a new way of thinking about how clinical research is conducted and breaking down competitive barriers for the greater good. Crowdsourcing is the process of getting work or funding, usually online,...

    By Denise Myshko • Oct. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Beyond Medical Marijuana

    The broad reaching war on drugs that began more than 40 years ago had an unintended consequence: research on the therapeutic value of controlled substances such marijuana, psychedelics, narcotics, and stimulants stalled. Controlled substances were difficult for researchers to get and research was...

    By Denise Myshko • Oct. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    A New Way to Address Drug-Resistant Infections Magnus Precht, CEO and Co-founder of SinSa Labs, talks about his company’s work to develop a new class of antibiotics engineered to avert antibiotic resistance. Experts say in the future, the crisis in antibiotic resistance will be in E. coli, Klebsi...

    By Magnus Precht of SinSa Labs • Sept. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Network

    Social Media Plays Crucial Role In Patient Recruitment For Diabetes Clinical Trial Trending Now: Social media improves clinical study operations. Dr. Frank Waldron-Lynch from the University of Cambridge implemented a research study to analyze the performance of three recruitment sources and the e...

    By PharmaVoice Team • Sept. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Pharma Trax

    Understanding of Therapeutic Value of Cancer Drugs Increases after Initial Approval Trending now: Ongoing research and real-world application post-approval often reveal greater benefit of cancer therapies. The full therapeutic value of a cancer therapy is typically realized long after the drug’s ...

    By PharmaVoice Team • Sept. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Tools of the Trade

    First Medidata-Sponsored Clinical Trial Assesses Capability of mHealth Tools Trending Now: New study explores potential for providing patients with mobile health tools in a clinical trial setting. Medidata, a leading global provider of cloud-based solutions for clinical research in life sciences,...

    By PharmaVoice Team • Sept. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Calendar

    Coming Attractions The Healthcare Businesswomen’s Association’s (HBA) Annual Conference — Influence and Impact: Imagine the Possibilities — will take place November 3-5, 2015, at the Marriott Marquis in Atlanta. More than 1,200 executives — women and men — will convene to engage in meaningful dia...

    By PharmaVoice Team • Sept. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Biotech Pool Dr. Nathalie Adda Enanta Names Chief Medical Officer Enanta Pharmaceuticals, a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, has appointed Nathalie Adda, M.D., as senior VP and chief medical ...

    By PharmaVoice Team • Sept. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    A Unique Approach to Regenerative Medicine Karine Kleinhaus, M.D., Divisional VP, North America, Pluristem Therapeutics, discusses how the emerging wave of  regenerative and cell therapies could potentially improve the longevity and quality of life of patients living with chronic diseases. PV: Wh...

    By Karin Kleinhaus • Sept. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Gene Therapy: Delivering on the Promise

    It’s been 16 years since tragedy struck in the clinical research world. A patient in an experimental gene therapy trial died just days after receiving the therapy. In 1999, Jesse Gelsinger came to the University of Pennsylvania with a rare metabolic disorder that prevents the body from breaking d...

    By Denise Myshko • Sept. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    C-Suite: Clinical Service

    Contract Research Organizations C-Suite executives from some of the industry’s leading CROs provide their insights on where the greatest opportunities lie for improving clinical research operations, the greatest challenges involved with the trial process, and best practices to enhance clinical op...

    By Taren Grom • Sept. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Celebrating Inspiration When we first conceptualized this special issue 11 years ago, the idea was that it would be nice to showcase the people who are having a positive impact on the industry. We didn’t know then that this issue would come to mean so much more than a metaphoric high five. Over t...

    By Taren Grom • Aug. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Who's on the list by Company

    AbelsonTaylor Inc.    Keith Stenlund Achillion Pharmaceuticals    Kevin Kucharski Advanced Clinical LLC    Leo Sheridan Alcobra Pharma    David Baker Altasciences    Chris Perkin AmerisourceBergen Corp.    Marc Kikuchi Artcraft Health    Marc Sirockman Astellas Pharma US Inc.    Jim Robinson Astr...

    By PharmaVoice Team • Aug. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Tools of the Trade

    TGaS Advisors Launches Emerging Life Sciences Network  Trending Now: The network provides peer support, data, and insights for accelerating commercial success. TGaS Advisors, a benchmarking and advisory services firm for life-sciences commercial organizations, has launched the Emerging Life Scien...

    By PharmaVoice Team • Aug. 1, 2015